Summary

Global Defibrillator Market is valued at approximately USD 12.84 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.9% over the forecast period 2023-2030. A defibrillator is a medical device used to administer controlled electrical shocks to the heart during life-threatening cardiac arrhythmias like ventricular fibrillation and pulseless ventricular tachycardia. These irregular rhythms can lead to sudden cardiac arrest. Defibrillators work by briefly halting all heart electrical activity, allowing the heart's natural rhythm to resume. There are various types of defibrillators, including Automated External Defibrillators (AEDs), Manual Defibrillators used by medical professionals, and Implantable Cardioverter-Defibrillators (ICDs) for high-risk patients. Defibrillators are critical emergency tools in restoring normal heart rhythm and increasing survival rates during cardiac emergencies. The growing focus on providing public-access defibrillators, rising training and awareness programs on defibrillators, coupled with the increasing healthcare expenditure are the key factors that are propelling the market demand across the globe.

In addition, the rising prevalence of cardiovascular diseases such as coronary artery disease, arrhythmias, and heart failure is a catalyzing factor for the defibrillator market. Also, cardiovascular diseases remain a prominent cause of global mortality, resulting in the demand for defibrillators for both preventive measures and emergency interventions on the rise. For instance, the British Heart Foundation (BHF) data published in January 2022 reported that in 2021, the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million) and atrial fibrillation (60 million). The report also mentioned that the prevalence of heart and circulatory diseases in North America was 46 million, in Europe 99 million, in Africa 58 million, in South America 32 million, and in Asia and Australia 310 million in 2021. Thus, these aforementioned factors are propelling the growth of the Defibrillator Market during the estimated period. Moreover, the surge in technological advancements and introduction of innovative devices, as well as increasing government & healthcare initiatives present various lucrative opportunities over the forecast years. However, the stringent regulatory framework and the high cost of the devices are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Defibrillator Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing prevalence of heart diseases, a growing elderly population, a robust presence of industry players, and a well-developed healthcare infrastructure in the region. There is growing awareness among the public and healthcare stakeholders regarding available technologies, as evidenced by data from the Centers for Disease Control and Prevention indicating that approximately 695,000 individuals in the U.S. died from heart disease in 2021 (representing 1 in every 5 deaths). Furthermore, the rising incidence of heart-related disorders and continuous technological advancements are key drivers propelling regional market growth. Whereas Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rise in the trend of sedentary lifestyles, unhealthy dietary habits, and a rising ageing population, leads to increased incidences of cardiovascular diseases (CVD), which are significantly propelling the market demand across the region. This trend has created a higher demand for effective treatment options such as defibrillators. For instance, in December 2022, the "2022 Report on Global Burden of Cardiovascular Diseases and Risk" revealed that the high-income Asia Pacific region reported 76.6 deaths per 1 lakh individuals, boasting the lowest age-standardized total CVD mortality rate. In contrast, Central Asia registered 516.9 deaths per 1 lakh people, with a higher age-standardized total CVD mortality rate. This high prevalence of CVD has resulted in a rising number of cardiology intervention procedures in the region, thereby driving market growth.

Major market players included in this report are:
Medtronic PLC (Ireland)
Stryker Corporation (US)
Koninklijke Philips N.V. (Netherlands)
Asahi Kasei Corporation (Japan)
Boston Scientific Corporation (US)
Abbott Laboratories (US)
MicroPort Scientific Corporation (China)
Nihon Kohden Corporation (Japan)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
Biotronik (Germany)

Recent Developments in the Market:
 In September 2022, Kauvery Hospital introduced the Restart Heart Foundation in Chennai, India, deploying over 100 automated external defibrillators at strategic locations across the city.
 In August 2022, Medtronic announced that its investigational EV ICD (extravascular implantable cardioverter defibrillator) system achieved trial endpoints. Unlike traditional transvenous ICDs, this device minimizes certain risks by placing the lead outside the heart and veins, beneath the sternum, using a minimally invasive technique.

Global Defibrillator Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Type, Patients Type, End Users, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
 Customization Scope - Free report customization (equivalent to up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Implantable cardioverter defibrillators
Transvenous implantable cardioverter defibrillators
Subcutaneous implantable cardioverter defibrillators
External defibrillators
Manual & semi-automated external defibrillators
Fully automated external defibrillators
Wearable cardioverter defibrillators

By Patients Type:
Adult
Pediatrics

By End Users:
Hospitals, Clinics and Cardiac Centers
Pre-Hospital Care Settings
Public Access Markets
Home Care Settings
Alternate Care Facilities
Other End Users

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Defibrillator Market, by Region, 2020-2030 (USD Billion)
1.2.2. Defibrillator Market, by Type, 2020-2030 (USD Billion)
1.2.3. Defibrillator Market, by Patients Type, 2020-2030 (USD Billion)
1.2.4. Defibrillator Market, by End Users, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Defibrillator Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Defibrillator Market Dynamics
3.1. Defibrillator Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing focus on providing public-access defibrillators
3.1.1.2. Rising prevalence of cardiovascular diseases
3.1.2. Market Challenges
3.1.2.1. Stringent regulatory framework
3.1.2.2. High cost of the devices
3.1.3. Market Opportunities
3.1.3.1. Surge in technological advancements and introduction of innovative devices
3.1.3.2. Increasing government & healthcare initiatives
Chapter 4. Global Defibrillator Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Defibrillator Market, by Type
5.1. Market Snapshot
5.2. Global Defibrillator Market by Type, Performance - Potential Analysis
5.3. Global Defibrillator Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Defibrillator Market, Sub Segment Analysis
5.4.1. Implantable cardioverter defibrillators
5.4.2. Transvenous implantable cardioverter defibrillators
5.4.3. Subcutaneous implantable cardioverter defibrillators
5.4.4. External defibrillators
5.4.5. Manual & semi-automated external defibrillators
5.4.6. Fully automated external defibrillators
5.4.7. Wearable cardioverter defibrillators
Chapter 6. Global Defibrillator Market, by Patients Type
6.1. Market Snapshot
6.2. Global Defibrillator Market by Patients Type, Performance - Potential Analysis
6.3. Global Defibrillator Market Estimates & Forecasts by Patients Type 2020-2030 (USD Billion)
6.4. Defibrillator Market, Sub Segment Analysis
6.4.1. Adult
6.4.2. Pediatrics
Chapter 7. Global Defibrillator Market, by End Users
7.1. Market Snapshot
7.2. Global Defibrillator Market by End Users, Performance - Potential Analysis
7.3. Global Defibrillator Market Estimates & Forecasts by End Users 2020-2030 (USD Billion)
7.4. Defibrillator Market, Sub Segment Analysis
7.4.1. Hospitals, Clinics and Cardiac centres
7.4.2. Pre-hospital care settings
7.4.3. Public access markets
7.4.4. Home care settings
7.4.5. Alternate care facilities
7.4.6. Other end users
Chapter 8. Global Defibrillator Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Defibrillator Market, Regional Market Snapshot
8.4. North America Defibrillator Market
8.4.1. U.S. Defibrillator Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Patients Type breakdown estimates & forecasts, 2020-2030
8.4.1.3. End Users breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Defibrillator Market
8.5. Europe Defibrillator Market Snapshot
8.5.1. U.K. Defibrillator Market
8.5.2. Germany Defibrillator Market
8.5.3. France Defibrillator Market
8.5.4. Spain Defibrillator Market
8.5.5. Italy Defibrillator Market
8.5.6. Rest of Europe Defibrillator Market
8.6. Asia-Pacific Defibrillator Market Snapshot
8.6.1. China Defibrillator Market
8.6.2. India Defibrillator Market
8.6.3. Japan Defibrillator Market
8.6.4. Australia Defibrillator Market
8.6.5. South Korea Defibrillator Market
8.6.6. Rest of Asia Pacific Defibrillator Market
8.7. Latin America Defibrillator Market Snapshot
8.7.1. Brazil Defibrillator Market
8.7.2. Mexico Defibrillator Market
8.8. Middle East & Africa Defibrillator Market
8.8.1. Saudi Arabia Defibrillator Market
8.8.2. South Africa Defibrillator Market
8.8.3. Rest of Middle East & Africa Defibrillator Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Medtronic PLC (Ireland)
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Stryker Corporation (US)
9.3.3. Koninklijke Philips N.V. (Netherlands)
9.3.4. Asahi Kasei Corporation (Japan)
9.3.5. Boston Scientific Corporation (US)
9.3.6. Abbott Laboratories (US)
9.3.7. MicroPort Scientific Corporation (China)
9.3.8. Nihon Kohden Corporation (Japan)
9.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
9.3.10. Biotronik (Germany)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption